Safety and efficacy of the biologic response modifiers

Am J Orthop (Belle Mead NJ). 2007 Mar;36(3 Suppl):15-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Antigens, CD20 / drug effects
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / metabolism
  • Humans
  • Immunologic Factors / therapeutic use*
  • Interleukin-1 / antagonists & inhibitors
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antigens, CD20
  • Immunologic Factors
  • Interleukin-1
  • Tumor Necrosis Factor-alpha